Helixgate

Helixgate

Uncategorized

STAT+: Axsome wins FDA nod for Alzheimer’s agitation

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

The FDA named Katherine Szarama acting head of CBER as it continues to search for a permanent leader. Julia Vitarello is launching a new effort to scale bespoke medicines after her first startup faltered.

And Matt Herper reflects on the legacy of genomics pioneer J. Craig Venter, whose vision helped shape modern biotech.

Continue to STAT+ to read the full story…

Read More

Published

on

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

The FDA named Katherine Szarama acting head of CBER as it continues to search for a permanent leader. Julia Vitarello is launching a new effort to scale bespoke medicines after her first startup faltered.

And Matt Herper reflects on the legacy of genomics pioneer J. Craig Venter, whose vision helped shape modern biotech.

Continue to STAT+ to read the full story…

Read More

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Uncategorized

Summit’s ‘self-inflicted’ stumble; Esperion’s take-private deal

Summit’s decision to conduct an interim analysis of a closely watched trial backfired. Elsewhere, Axsome got a much-needed label expansion and an FDA committee sided against an AstraZeneca breast cancer medicine.

Read More

Published

on

Summit’s decision to conduct an interim analysis of a closely watched trial backfired. Elsewhere, Axsome got a much-needed label expansion and an FDA committee sided against an AstraZeneca breast cancer medicine.

Read More

Continue Reading

Uncategorized

Samsung Biologics workers begin five-day strike over wage disputes 

Samsung Biologics workers begin five-day strike over wage disputes 

Published

on

After holding a rally in April, Samsung Biologics union workers on Friday started a five-day strike over wage negotiations.

Around 95% of the company’s union members voted on the strike, with the …​ ​Read More

Continue Reading

Uncategorized

Acelyrin founder Shao-Lee Lin emerges at Cue, as it becomes latest to license from China

Published

on

Cue Biopharma announced a reboot Thursday afternoon, bringing in notable biotech executive Shao-Lee Lin as well as a new allergy asset developed in Taiwan and mainland China.

The Boston-based biotech has focused on developing T …

Continue Reading
Advertisement

Trending